Roth Capital Lowers Earnings Estimates for Journey Medical
Journey Medical Co. (NASDAQ:DERM – Free Report) – Equities researchers at Roth Capital reduced their Q2 2025 earnings per share estimates for Journey Medical in a note issued to investors on Thursday, May 15th. Roth Capital analyst J. Wittes now expects that the company will earn ($0.08) per share for the quarter, down from their […]
Journey Medical Co. (NASDAQ:DERM – Free Report) – Equities researchers at Roth Capital reduced their Q2 2025 earnings per share estimates for Journey Medical in a note issued to investors on Thursday, May 15th. Roth Capital analyst J. Wittes now expects that the company will earn ($0.08) per share for the quarter, down from their […]
